HUBEI BIOCAUSE PH financial statements, including revenue, expenses, profit, and loss

The total revenue of 000627 for the last quarter is 48.24 B CNY, and it's 527.80% higher compared to the previous quarter. The net income of Q4 23 is -232.35 M CNY.